Overview
MetLife, Inc., based in the United States, is a prominent player in the global insurance industry. It offers a diverse range of financial and insurance products, including life, dental, automotive, and disability insurance, along with annuities and employee benefit programs, catering to both individual and corporate clients. Harnessing its expansive network across the Americas, Asia, and Europe, MetLife focuses on continuous innovation in products and services. Key projects include technological enhancements through digital platforms, such as MetLife's "MetLife Digital Accelerator" which teams up with tech startups to drive transformation and customer engagement. The company is also significantly investing in sustainability initiatives aimed at reducing its environmental footprint and promoting environmental, social, and governance (ESG) standards across its operations.
Basic Stats
The Factor Analysis chart (below right) shows a view of MetLife, Inc. - Preferred Stock from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 666.80 MM |
| Earnings Date | |
| EPS (TTM) | 6.43 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-29 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | 0.03 MM |
| Short Float | |
| Days to Cover | 1.00 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.01 |
| ROE | 0.16 |
| ROIC | 0.06 |
| CROIC | 0.02 |
| OCROIC | 0.22 |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for MetLife, Inc. - Preferred Stock is $538.70. The forecasts range from a low of $484.25 to a high of $636.52. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for MetLife, Inc. - Preferred Stock. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2012-12-13 | Sterne Agee | Buy | Maintains | |
| 2022-08-17 | Morgan Stanley | Overweight | Maintains | |
| 2022-08-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-14 | Barclays | Overweight | Maintains | |
| 2022-07-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-06 | Evercore ISI Group | Outperform | Maintains | |
| 2022-06-23 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2022-05-24 | Citigroup | Buy | Initiate | |
| 2022-05-05 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-12 | Barclays | Overweight | Maintains | |
| 2022-04-06 | Piper Sandler | Overweight | Maintains | |
| 2024-07-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-07-08 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2024-07-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-06-28 | Jefferies | Buy | Buy | Maintains |
| 2024-05-22 | Argus Research | Buy | Buy | Maintains |
| 2024-05-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-05-07 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2024-05-06 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-04-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-04-11 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-10 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2024-04-05 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-02-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-05 | UBS | Buy | Buy | Maintains |
| 2024-01-10 | UBS | Buy | Buy | Maintains |
| 2024-01-09 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-01-08 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2023-12-07 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2023-11-17 | Barclays | Overweight | Reiterate | |
| 2023-11-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-09-14 | Jefferies | Hold | Buy | Upgrade |
| 2023-08-18 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-15 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-14 | Argus Research | Buy | Buy | Maintains |
| 2023-08-09 | Citigroup | Buy | Buy | Maintains |
| 2023-08-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-03 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2023-07-17 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-06-15 | Citigroup | Buy | Buy | Maintains |
| 2023-06-09 | Keefe, Bruyette & Woods | Outperform | Reiterate | |
| 2023-06-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-05-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-05-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-05-05 | RBC Capital | Outperform | Maintains | |
| 2023-04-20 | RBC Capital | Outperform | Maintains | |
| 2023-04-12 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-12 | Barclays | Overweight | Maintains | |
| 2023-04-05 | Piper Sandler | Overweight | Maintains | |
| 2023-04-05 | Wells Fargo | Overweight | Maintains | |
| 2023-04-05 | Goldman Sachs | Neutral | Maintains | |
| 2023-02-02 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-18 | Wells Fargo | Overweight | Maintains | |
| 2023-01-10 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-09 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2023-01-06 | JP Morgan | Overweight | Maintains | |
| 2022-12-09 | Jefferies | Buy | Hold | Downgrade |
| 2022-11-17 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-03 | JP Morgan | Overweight | Maintains | |
| 2022-11-03 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-12 | Wells Fargo | Overweight | Maintains | |
| 2022-09-22 | Raymond James | Market Perform | Initiate | |
| 2022-08-22 | Credit Suisse | Outperform | Maintains | |
| 2022-01-04 | Wells Fargo | Overweight | Maintains | |
| 2021-12-03 | Goldman Sachs | Buy | Initiate | |
| 2021-10-14 | Morgan Stanley | Overweight | Maintains | |
| 2021-10-12 | Barclays | Overweight | Maintains | |
| 2021-08-05 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-15 | Morgan Stanley | Overweight | Maintains | |
| 2021-06-21 | Citigroup | Buy | Maintains | |
| 2021-05-13 | Credit Suisse | Outperform | Maintains | |
| 2021-05-06 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-21 | UBS | Buy | Initiate | |
| 2021-04-01 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-25 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2021-01-15 | Morgan Stanley | Overweight | Maintains | |
| 2021-01-06 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2020-12-08 | Citigroup | Neutral | Buy | Upgrade |
| 2020-11-18 | Morgan Stanley | Overweight | Maintains | |
| 2020-11-17 | Credit Suisse | Outperform | Maintains | |
| 2022-02-22 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-26 | Jefferies | Buy | Initiate | |
| 2022-01-21 | Wolfe Research | Peer Perform | Initiate | |
| 2022-01-11 | Barclays | Overweight | Maintains | |
| 2022-01-07 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-05 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2019-07-16 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-07-11 | Wells Fargo | Outperform | Maintains | |
| 2019-07-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-05-22 | Barclays | Overweight | Maintains | |
| 2019-04-12 | Deutsche Bank | Hold | Hold | Maintains |
| 2019-04-09 | UBS | Neutral | Neutral | Maintains |
| 2019-03-19 | Sandler O'Neill | Buy | Hold | Downgrade |
| 2019-01-16 | Bank of America | Neutral | Buy | Upgrade |
| 2018-12-17 | RBC Capital | Outperform | Outperform | Maintains |
| 2018-11-13 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-08 | UBS | Neutral | Neutral | Maintains |
| 2018-08-17 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-07-16 | B. Riley FBR | Neutral | Neutral | Maintains |
| 2018-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-07-09 | Barclays | Overweight | Overweight | Maintains |
| 2020-11-05 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-06 | Morgan Stanley | Overweight | Maintains | |
| 2020-08-20 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-06 | Morgan Stanley | Overweight | Maintains | |
| 2020-05-08 | RBC Capital | Outperform | Maintains | |
| 2020-05-07 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-27 | Credit Suisse | Outperform | Maintains | |
| 2020-04-03 | Piper Sandler | Neutral | Maintains | |
| 2020-04-01 | Wells Fargo | Overweight | Maintains | |
| 2020-03-17 | Citigroup | Sell | Neutral | Upgrade |
| 2020-03-17 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-10 | Piper Sandler | Neutral | Maintains | |
| 2020-02-27 | Piper Sandler | Neutral | Maintains | |
| 2020-02-03 | Credit Suisse | Outperform | Maintains | |
| 2020-01-23 | B of A Securities | Buy | Maintains | |
| 2020-01-07 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2019-10-10 | UBS | Neutral | Maintains | |
| 2019-09-13 | Citigroup | Sell | Maintains | |
| 2019-08-20 | Morgan Stanley | Equal-Weight | Maintains | |
| 2018-06-04 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-05-04 | Deutsche Bank | Hold | Hold | Maintains |
| 2018-04-25 | Credit Suisse | Outperform | Initiate | |
| 2018-04-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-03-26 | Atlantic Equities | Neutral | Overweight | Upgrade |
| 2018-03-02 | UBS | Neutral | Neutral | Maintains |
| 2018-02-14 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-01-30 | Wells Fargo | Outperform | Maintains | |
| 2017-11-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-11-10 | Sandler O'Neill | Buy | Hold | Downgrade |
| 2017-11-06 | Argus | Buy | Maintains | |
| 2017-11-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-10-18 | Goldman Sachs | Buy | Initiate | |
| 2017-10-10 | FBR Capital | Buy | Neutral | Downgrade |
| 2017-10-05 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-08-28 | Credit Suisse | Neutral | Maintains | |
| 2017-08-11 | Barclays | Overweight | Maintains | |
| 2017-08-09 | Argus | Buy | Maintains | |
| 2017-05-25 | FBR Capital | Market Perform | Outperform | Upgrade |
| 2017-03-06 | Bank of America | Buy | Neutral | Downgrade |
| 2017-01-26 | Citigroup | Sell | Initiate | |
| 2017-01-23 | Deutsche Bank | Hold | Buy | Upgrade |
| 2016-11-28 | FBR Capital | Outperform | Market Perform | Downgrade |
| 2016-10-07 | Credit Suisse | Neutral | Initiate | |
| 2016-07-13 | Deutsche Bank | Buy | Hold | Downgrade |
| 2016-07-07 | Citigroup | Neutral | Maintains | |
| 2016-07-07 | Deutsche Bank | Buy | Maintains | |
| 2016-06-27 | Sandler O'Neill | Hold | Buy | Upgrade |
| 2016-05-05 | JP Morgan | Overweight | Maintains | |
| 2016-02-08 | FBR Capital | Outperform | Maintains | |
| 2016-02-04 | Macquarie | Outperform | Maintains | |
| 2016-02-04 | Barclays | Overweight | Maintains | |
| 2016-01-22 | Raymond James | Market Perform | Strong Buy | Upgrade |
| 2016-01-14 | Macquarie | Neutral | Outperform | Upgrade |
| 2016-01-14 | Deutsche Bank | Buy | Maintains | |
| 2016-01-05 | Citigroup | Buy | Neutral | Downgrade |
| 2015-11-11 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2015-11-06 | Deutsche Bank | Buy | Maintains | |
| 2015-10-12 | Keefe Bruyette & Woods | Outperform | Maintains | |
| 2015-10-05 | JP Morgan | Overweight | Maintains | |
| 2015-07-15 | Deutsche Bank | Buy | Maintains | |
| 2015-07-02 | Citigroup | Buy | Maintains | |
| 2015-06-22 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2015-05-15 | Goldman Sachs | Neutral | Initiate | |
| 2015-05-08 | Deutsche Bank | Buy | Maintains | |
| 2015-04-09 | Deutsche Bank | Buy | Maintains | |
| 2015-02-17 | Citigroup | Buy | Maintains | |
| 2015-01-27 | Keefe Bruyette & Woods | Outperform | Maintains | |
| 2015-01-07 | Deutsche Bank | Buy | Maintains | |
| 2014-12-17 | Citigroup | Buy | Maintains | |
| 2014-12-15 | Keefe Bruyette & Woods | Market Perform | Maintains | |
| 2014-12-03 | Atlantic Equities | Neutral | Initiate | |
| 2014-10-13 | Sterne Agee | Buy | Maintains | |
| 2014-07-17 | Sterne Agee | Buy | Maintains | |
| 2014-07-14 | Deutsche Bank | Buy | Maintains | |
| 2014-07-09 | Citigroup | Buy | Maintains | |
| 2014-07-07 | Drexel Hamilton | Buy | Initiate | |
| 2014-07-01 | JP Morgan | Overweight | Maintains | |
| 2014-06-11 | Barclays | Overweight | Maintains | |
| 2014-05-01 | Keefe Bruyette & Woods | Outperform | Initiate | |
| 2014-01-08 | Citigroup | Neutral | Buy | Upgrade |
| 2014-01-06 | UBS | Buy | Neutral | Downgrade |
| 2014-01-03 | Janney Capital | Neutral | Buy | Upgrade |
| 2013-12-13 | Credit Suisse | Outperform | Maintains | |
| 2013-11-15 | Deutsche Bank | Buy | Maintains | |
| 2013-09-20 | Goldman Sachs | Buy | Maintains | |
| 2013-09-04 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2013-07-18 | Deutsche Bank | Buy | Maintains | |
| 2013-07-12 | Raymond James | Outperform | Perform | Downgrade |
| 2013-06-03 | Deutsche Bank | Hold | Buy | Upgrade |
| 2013-04-03 | JP Morgan | Overweight | Maintains | |
| 2013-02-21 | Deutsche Bank | Hold | Maintains | |
| 2013-01-10 | Citigroup | Neutral | Initiate | |
| 2013-01-09 | Citigroup | Neutral | Initiate | |
| 2013-01-08 | Deutsche Bank | Hold | Initiate | |
| 2012-12-13 | Morgan Stanley | Overweight | Maintains | |
| 2012-12-06 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2012-08-10 | UBS | Buy | Maintains | |
| 2012-07-18 | UBS | Buy | Initiate | |
| 2012-07-10 | JP Morgan | Overweight | Maintains | |
| 2012-07-02 | Barclays | Overweight | Maintains | |
| 2024-11-27 | TD Cowen | Buy | Buy | Maintains |
| 2024-07-23 | Citigroup | Buy | Buy | Maintains |
| 2024-09-27 | Jefferies | Buy | Buy | Maintains |
| 2024-10-31 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-02 | UBS | Buy | Buy | Maintains |
| 2025-04-02 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-04-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-07-18 | Jefferies | Buy | Buy | Maintains |
| 2024-10-02 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-01-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-23 | BMO Capital | Market Perform | Initiate | |
| 2025-02-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-01 | B of A Securities | Buy | Buy | Maintains |
| 2024-10-09 | TD Cowen | Buy | Initiate | |
| 2024-09-04 | Barclays | Overweight | Initiate | |
| 2025-02-12 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2025-01-07 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-08-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-01-06 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-12 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-07 | UBS | Buy | Buy | Maintains |
| 2025-04-11 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-04-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-28 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-10-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-11 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2025-08-11 | Jefferies | Buy | Buy | Maintains |
| 2025-02-19 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-09 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2025-07-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-09 | Keefe, Bruyette & Woods | Outperform | Outperform | Maintains |
| 2025-05-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-05-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-18 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-07 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-14 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-08 | JP Morgan | Overweight | Overweight | Maintains |
